Provident Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Provident Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.5K	Hold	300	–	–	0.01%	134
2026 Q1	$38.3K	Hold	300	–	–	0.01%	120
2025 Q4	$36.6K	Hold	300	–	–	0.01%	123
2025 Q3	$30.1K	Hold	300	–	–	0.01%	124
2025 Q2	$24.9K	Sell	300 -10	-3%	-$798	0.01%	122
2025 Q1	$25.1K	Buy	310 +300	+3,000%	+$26.8K	0.01%	120
2024 Q4	$901	Buy	+10	New	+$969	﹤0.01%	122
2023 Q2	–	Sell	-50	Closed	-$3.81K	–	101
2023 Q1	$3.81K	Buy	+50	New	+$4.15K	﹤0.01%	89

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Provident Wealth Management's XBI Position: Q2 2026 in Review

Provident Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 300 shares worth $47.5K. The position accounts for 0.01% of the portfolio, ranked #134.

Provident Wealth Management first reported a position in XBI in Q1 2023 and has held it in 8 quarters since. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Provident Wealth Management held 300 shares of State Street SPDR S&P Biotech ETF worth $47.5K as of Q2 2026.
Provident Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Provident Wealth Management's portfolio in Q2 2026, its #134 holding.
Provident Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 8 quarters since.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Provident Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.